EPCAM and neoplasm: The authors show that EVs isolated from BrCa cell lines or OvCa ascites bound and sequestered tumour-reactive antibodies, such as the therapeutical anti-HER2 monoclonal antibody trastuzumab and an anti-EPCAM tumor-reactive antibody.